Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamiker Biotechnology (Tianjin) CoBJSE:920009 46 Interest Coverage is 809.05 as of Mar. 2026, which is 167% above its 10-year median of 303.35. GuruFocus rates BJSE:920009 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 687 Drug Manufacturers companies, Dynamiker Biotechnology (Tianjin) Co ranks better than 88.21% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Dynamiker Biotechnology (Tianjin) Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥17.8 Mil. Dynamiker Biotechnology (Tianjin) Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0.0 Mil.
Dynamiker Biotechnology (Tianjin) Co's interest coverage for the quarter that ended in Mar. 2026 was 809.05.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Dynamiker Biotechnology (Tianjin) Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
BJSE:920009'
s Interest Coverage Range Over the Past 10 Years
Min: 49.08 Med: 303.35 Max: No Debt
Current: 298.33
BJSE:920009's Interest Coverage is ranked better than 88.21% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs BJSE:920009: 298.33
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Dynamiker Biotechnology (Tianjin) Co Interest Coverage Related Terms
Dynamiker Biotechnology (Tianjin) Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Dynamiker Biotechnology (Tianjin) Co Interest Coverage Chart
BJSE:920009 vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamiker Biotechnology (Tianjin) Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's Interest Coverage falls into.
Dynamiker Biotechnology (Tianjin) Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a Interest Coverage of 809.05 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. This is 167% above median its historical median of 303.35. Over the past decade, Dynamiker Biotechnology (Tianjin) Co's Interest Coverage has ranged from 49.08 to 10,000.00. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #81 out of 687 companies in the Drug Manufacturers industry, placing it in the top 11.8%.
Is Dynamiker Biotechnology (Tianjin) Co's Interest Coverage too high?
Dynamiker Biotechnology (Tianjin) Co's current Interest Coverage of 809.05 is 167% above median its 10-year median of 303.35. Over the past 10 years, this metric has ranged from a low of 49.08 to a high of 10,000.00. The Drug Manufacturers industry median Interest Coverage is 12.75. Dynamiker Biotechnology (Tianjin) Co's value of 809.05 is 6245.5% above this industry median. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #81 out of 687 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #81 out of 687 companies for Interest Coverage. This places Dynamiker Biotechnology (Tianjin) Co in the top 12% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.75. Dynamiker Biotechnology (Tianjin) Co's value of 809.05 is 6245.5% above this benchmark. Historically, Dynamiker Biotechnology (Tianjin) Co's own Interest Coverage has ranged from 49.08 to 10,000.00 over the past decade. While the company's 10-year median is 303.35 vs. the industry median of 12.75, Dynamiker Biotechnology (Tianjin) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamiker Biotechnology (Tianjin) Co's current Interest Coverage of 809.05 is 6245.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current Interest Coverage is 809.05, which is 167% above median its own 10-year median of 303.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current Interest Coverage of 809.05. The current Interest Coverage is 809.05, which is 167% above median its 10-year median of 303.35 and 6245.5% above the Drug Manufacturers industry median of 12.75. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current Interest Coverage is 809.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score
Get the complete analysis for BJSE:920009
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920009 has been successfully added to your 
